Fusion event
HBV-LOC105369363 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
68051170/68283702 (Hg38)
Nearest miRNA
hsa-mir-10392/Upstream/238745; hsa-let-7a-2/Downstream/799474;
Upstream sequence
gcaagctctgcctcccaagttcacgttattctgcctcagcctcctgagtagctgggaccacaggcgcctgccaccacacctggctaattttttttgtatt
Downstream sequence
tttagtagagatggggtttcaccatgttagccaggatggtctcgatctcctgacctcatgatccacccgccttggcctcccaaagtgctgggattacagg
Target sequence
ACCCCAAATTGAGACTCAGCTCACTGCCTACTGACTCAGCTCACCAGAGTCTTGCTGCCGGCCCCTCCACTTCCTCTTCTTTGCTATTGCAGGGTGGCAGGTTGAGTTGAGAACAGTTGCTTACAAAGTGAGCAATCCCCTTCCAAGCCAGCCTGCCTCTGTCTCTTTGATTCTACCAGTAATTGAGCTTTGTGTTTCCCCATGGGCTCATGTATCTTTCAGCAAGGTTTTAAAGTGCTTTTCCTCTCCAGCAGT
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.